L01EX13 Gilteritinib
ATC class of level 5 – chemical substance
This page lists the patient medication information or the product monograph for 1 drug in this drug class.
- 1 prescription (Rx)
Active ingredient: Gilteritinib (gilteritinib fumarate) – all drugs with this active ingredient, also in combination.
Place in the ATC system
- L Antineoplastic and immunomodulating agents 1,167 drugs
- L01 Antineoplastic agents 662 drugs
- L01E Protein kinase inhibitors, antineoplastic and immunomodulating agents 131 drugs
- L01EX Other protein kinase inhibitors 34 drugs
- L01EX13 Gilteritinib 1 drug
- L01EX Other protein kinase inhibitors 34 drugs
- L01E Protein kinase inhibitors, antineoplastic and immunomodulating agents 131 drugs
- L01 Antineoplastic agents 662 drugs
Drugs in the class
| Drug | Rx or OTC |
|---|---|
| Xospata PM | prescription (Rx) |
Other classes of the same level
- L01EX01 Sunitinib 7 drugs
- L01EX02 Sorafenib 2 drugs
- L01EX03 Pazopanib 5 drugs
- L01EX04 Vandetanib 1 drug
- L01EX05 Regorafenib 1 drug
- L01EX07 Cabozantinib 1 drug
- L01EX08 Lenvatinib 1 drug
- L01EX09 Nintedanib 5 drugs
- L01EX10 Midostaurin 1 drug
- L01EX11 Quizartinib 1 drug
- L01EX12 Larotrectinib 1 drug
- L01EX14 Entrectinib 1 drug
- L01EX18 Avapritinib 1 drug
- L01EX19 Ripretinib 1 drug
- L01EX22 Selpercatinib 1 drug
- L01EX23 Pralsetinib 1 drug
- L01EX27 Capivasertib 1 drug
- L01EX28 Repotrectinib 1 drug
Other names of the drug class
- English (United Kingdom): L01EX13 gilteritinib
- German: L01EX13 Gilteritinib
- German (Austria): L01EX13 Gilteritinib
- Italian: L01EX13 Gilteritinib
- Turkish: L01EX13 gilteritinib
- German (Switzerland): L01EX13 Gilteritinib
- French (Switzerland): L01EX13 Gilteritinib
- Italian (Switzerland): L01EX13 Gilteritinib
- French (Canada): L01EX13 Gilteritinib
- Slovak: L01EX13 Gilteritinib
- Spanish: L01EX13 Gilteritinib
- Czech: L01EX13 Gilteritinib
Sources
- Patient medication information and product monographs: Health Canada, Drug Product Database
- Active ingredients, ATC codes and Rx or OTC status: Health Canada, Drug Product Database
- World Health Organization (WHO): ATC/DDD system, class L01EX13
Ask your doctor or pharmacist for advice.